<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="48">
  <stage>Registered</stage>
  <submitdate>20/07/2005</submitdate>
  <approvaldate>26/07/2005</approvaldate>
  <actrnumber>ACTRN12605000042640</actrnumber>
  <trial_identification>
    <studytitle>The Childhood Asthma Prevention Study</studytitle>
    <scientifictitle>House dust mite allergen avoidance and omega 3 fatty acid supplementation to reduce the incidence of asthma in children with a family history.</scientifictitle>
    <utrn />
    <trialacronym />
  </trial_identification>
  <conditions>
    <healthcondition>Asthma</healthcondition>
    <conditioncode>
      <conditioncode1>Respiratory</conditioncode1>
      <conditioncode2>Asthma</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>House dust mite aviodance and omega-3 fatty acid supplementation.</interventions>
    <comparator />
    <control>Placebo</control>
    <interventioncode>Prevention</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Atopy (one or more skin tests greater than 2mm) using ATS criteria.</outcome>
      <timepoint />
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Symptom severity as defined the NAC (infrequent episodic, frequent episodic or persistent asthma) using ATS criteria.</outcome>
      <timepoint />
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Wheeze frequency using ATS criteria.</outcome>
      <timepoint />
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Possible asthma or current asthma using ATS criteria.</outcome>
      <timepoint />
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Eczema</outcome>
      <timepoint />
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Night cough</outcome>
      <timepoint />
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Allergic symptoms</outcome>
      <timepoint />
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Family history of asthma ie families with a parent or child with current asthma, fluency in English, no cat as a family pet and a phone at home.</inclusivecriteria>
    <inclusiveminage>0</inclusiveminage>
    <inclusiveminagetype>Not stated</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>Not stated</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>No exclusion criteria</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Prevention</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>The allocation was assigned using sequentially numbered sealed envelopes. The research nurses were responsible for recruiting participants and assigning participants to groups. The research team responsible for recruitment was blinded to the methods of randomization until recruitment was complete.</concealment>
    <sequence>The random sequence was generated using Microsoft Excel random number generation facility.</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Factorial</assignment>
    <designfeatures>Please note that the diet intervention was placebo controlled but the house dust mite intervention was not</designfeatures>
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 3</phase>
    <anticipatedstartdate>1/04/1997</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>600</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Closed: follow-up continuing</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Government body</primarysponsortype>
    <primarysponsorname>Woolcock Institute of Medical Research</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Government body</fundingtype>
      <fundingname>NHMRC</fundingname>
      <fundingaddress />
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>Other</fundingtype>
      <fundingname>CRC for Asthma</fundingname>
      <fundingaddress />
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Hospital</sponsortype>
      <sponsorname>CHW</sponsorname>
      <sponsoraddress />
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
    <secondarysponsor>
      <sponsortype>Hospital</sponsortype>
      <sponsorname>Liverpool Hospital</sponsorname>
      <sponsoraddress />
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>In this study we are testing a public health intervention to reduce the incidence of childhood asthma.  The two interventions that we are testing, that is housedust mite allergen avoidance and omega-3 fatty acid supplementation, are based on the strongest risk factors for asthma that have been identified in observational studies to date. This is the first trial in the world to test whether interventions directed at a potent causative factor (housedust mite allergens) or a protective factor (omega-3 fatty acids) can halt or reverse the increasing prevalence of childhood asthma.  If either of these interventions is effective, we will have the potential for the very first time to significantly reduce the incidence of asthma in young children.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>University of Sydney</ethicname>
      <ethicaddress />
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>the Children's Hospital at Westmead</ethicname>
      <ethicaddress />
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>the Western and South Western Sydney Area Heath Services</ethicname>
      <ethicaddress />
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Seema Mihrshahi</name>
      <address>Children's Hospital Westmead
Locked Bag 4001 
Westmead NSW 2145</address>
      <phone>+61 2 98453061</phone>
      <fax>+61 2 98453082</fax>
      <email>seemam@chw.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Guy Marks</name>
      <address>Woolcock Institute of Medical Research
University of Sydney
Level 6 Building F
88 Mallet St
Camperdown NSW 2050</address>
      <phone>+61 2 95158631</phone>
      <fax />
      <email>G.Marks@unsw.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>